CDC Advisers Say High-Risk Men Should Still Get Mpox Vaccine
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, Oct. 26, 2023 -- High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisers to the U.S. Centers for Disease Control and Prevention recommended Wednesday.
That vulnerable group includes men who have sex with men; people who have more than one sexual partner; those who have recently had a sexually transmitted disease; and people who are at higher risk for infections through sexual contact for other reasons.
CDC Director Mandy Cohen will still need to sign off on that recommendation, which came during a meeting of the CDC Advisory Committee on Immunization Practices.
The virus, formerly called monkeypox, is in the same family of viruses as smallpox and is endemic in parts of Africa. About 800 cases of mpox have been reported in the United States in 2023 compared with 30,000 last year, according to the CDC. In 2022, cases spread widely among men who have sex with men in Europe and the United States.
Now, the daily average of new cases is one to four per day. Two deaths were reported in September, while a total of 54 have died in the U.S. outbreaks, the Associated Press reported. Many suffered painful lesions for weeks. In San Francisco, where there were more than 800 cases last year, the numbers are now much lower although they vary. In August, there were seven, in September there were 20, and this month has had at least 10 known cases, the AP reported.
To stem the spread of mpox, the two-dose Jynneos vaccine has been distributed to more than 500,000 people in the United States. Still, about 2 million people are eligible for the shot, according to the CDC.
Associated Press Article
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
At-School Vaccination Boosts HPV Vaccination Coverage
THURSDAY, May 30, 2024 -- At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published...
Preparedness for HPAI A(H5N1) Virus Varies Across Jurisdictions
TUESDAY, May 21, 2024 -- Variation is seen in preparedness and response to highly pathogenic avian influenza (HPAI) A(H5N1) viruses, according to a research letter published...
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.